Anke has supported us already for several years in implementing bioanalytical strategies for our various biologics in development for treatment of orphan cancer indications in children. We have always appreciated her recommendations regarding the required bioassays and proposed CROs as well as her professional management of the outsourced activities, her flexibility and excellent communications.
Joris Wilms (MSc)
COO, Y-mAbs Therapeutics Inc., New York, USA
Based on her deep understanding of the drug development process, Anke has given very scientifically well-founded and pragmatic advice on many different preclinical topics. For this reason, Anke is the go-to preclinical advisor for Ascelia Pharma.
Andreas L. Norlin (MSc, PhD)
Project Director and Head of Preclinical Development, Ascelia Pharma AB, Malmö, Sweden
Anke has been collaborating with us on various client projects. We have engaged her for her strong interdisciplinary drug and vaccine development competencies and strategic thinking that allow her write lean, message-focused and consistent regulatory documents.
Dr. Ulrich Granzer
Granzer Regulatory Consulting and Services, München, Germany
Anke joined AimVion A/S to lead the company’s preclinical proof of concept activities. She is very capable, disciplined, accountable and she diligently creates clarity. She understands to engage for success only the best people around her. Anke is a true capacity, and I can only recommend her to anybody who needs a project executed to the highest standards and on time.
Hanne Damgaard Jensen (MSc, MBA)
Chairman of the Board, AimVion A/S, Copenhagen, Denmark
In support of our efforts to commercialise innovative treatment concepts invented by Universities of North Rhine Westphalia, we have engaged Anke at various occasions to analyse available scientific data, conduct a gap analysis and suggest the next development steps forward. We are very fond of Anke´s clearly laid out and concise recommendations.
Anke has supported the initiation of our cancer VLP vaccine project, from discovery through preclinical development, including implementation of project management. Anke has been professional in providing a project plan and communication with different stakeholders, both internally as well as with relevant external partners/ CROs. She has deep insight into drug development challenges and has been an important contributor in ensuring alignment on the solutions at hand.